Vial operates in the clinical trials market as a technology-driven Contract Research Organization (CRO). The company helps pharmaceutical and biotechnology clients conduct clinical trials more efficiently and at a larger scale. Its main product is the Vial Technology Platform, which replaces traditional paper-based methods with connected systems and an intuitive design, allowing for smoother transitions between different trial visits and phases. Vial differentiates itself from competitors by offering a fixed-fee pricing model, providing clients with cost certainty and maximizing their return on investment. The company's goal is to empower scientists to cure all human diseases by delivering faster and more efficient trials, while also contributing to industry knowledge through thought leadership initiatives.